Background: Mitosis is regulated by MPF (maturation promoting factor), the active form of Cdc2/28-cyclin B complexes. Increasing levels of cyclin B abundance and the loss of inhibitory phosphates from Cdc2/28 drives cells into mitosis, whereas cyclin B destruction inactivates MPF and drives cells out of mitosis. Cells with defective spindles are arrested in mitosis by the spindleassembly checkpoint, which prevents the destruction of mitotic cyclins and the inactivation of MPF. We have investigated the relationship between the spindleassembly checkpoint, cyclin destruction, inhibitory phosphorylation of Cdc2/28, and exit from mitosis.
Results:
The previously characterized budding yeast mad mutants lack the spindle-assembly checkpoint. Spindle depolymerization does not arrest them in mitosis because they cannot stabilize cyclin B. In contrast, a newly isolated mutant in the budding yeast CDC55 gene, which encodes a protein phosphatase 2A (PP2A) regulatory subunit, shows a different checkpoint defect. In the presence of a defective spindle, these cells separate their sister chromatids and leave mitosis without inducing cyclin B destruction. Despite the persistence of B-type cyclins, cdc55 mutant cells inactivate MPF. Two experiments show that this inactivation is due to inhibitory phosphorylation on Cdc28: phosphotyrosine accumulates on Cdc28 in cdc55⌬ cells whose spindles have been depolymerized, and a cdc28 mutant that lacks inhibitory phosphorylation sites on Cdc28 allows spindle defects to arrest cdc55 mutants in mitosis with active MPF and unseparated sister chromatids.
Conclusions:
We conclude that perturbations of protein phosphatase activity allow MPF to be inactivated by inhibitory phosphorylation instead of by cyclin destruction. Under these conditions, sister chromatid separation appears to be regulated by MPF activity rather than by protein degradation. We discuss the role of PP2A and Cdc28 phosphorylation in cell-cycle control, and the possibility that the novel mitotic exit pathway plays a role in adaptation to prolonged activation of the spindle-assembly checkpoint.
Background
Cell-cycle checkpoints coordinate the cell cycle by making one step dependent upon the successful completion of previous steps (reviewed in [1] [2] [3] ). Faithful transmission of genetic information depends on accurate chromosome segregation, which in turn requires a microtubule structure known as the mitotic spindle. Sister kinetochores in a replicated pair of sister chromatids are attached to opposite poles of the bipolar spindle, so that when they separate they are drawn apart, ensuring that each daughter cell receives one copy of each chromosome. The spindle-assembly checkpoint contributes to the accuracy of mitosis by delaying the onset of anaphase until the spindle has been fully assembled and each pair of sister chromatids is attached to it. Exit from mitosis depends on the proteolysis of cyclin B [4] , and sister separation appears to require the destruction of other proteins [5] [6] [7] ; the destruction of both sets of proteins requires a specific set of ubiquitinating enzymes [8] [9] [10] . Cyclin B destruction leads to the inactivation of MPF (maturation promoting factor or M-phase promoting factor), the Cdc2/28-cyclin B complex, whose activity is measured experimentally as histone H1 kinase [11] (Cdc28 is the budding yeast homolog of the fission yeast Cdc2 protein).
Our current understanding of the spindle-assembly checkpoint comes from a variety of approaches. Experimental manipulations of insect spermatocytes and vertebrate tissue culture cells suggest that kinetochores that have not attached to the spindle act to delay anaphase [12] [13] [14] , and have identified a kinetochore-associated phosphoepitope found only on those chromosomes that are improperly aligned on the spindle [15, 16] . Biochemical analysis shows that preventing spindle assembly in Xenopus egg extracts blocks cyclin B degradation and MPF inactivation, mimicking the mitotic arrest seen in nocodazole-treated tissue culture cells [17] . The MAP kinase ERK2 is required for proper functioning of the frog checkpoint, but neither the signal being detected, nor the mechanism by which cyclin degradation is blocked are known [17] .
Genetic analysis of budding yeast has identified multiple genes involved in the spindle assembly checkpoint (MAD1-3, BUB1-3 and MPS1) [18] [19] [20] [21] [22] [23] . Most of these genes were identified by mutations that allow cells to pass through mitosis without a fully assembled mitotic spindle. In the presence of a defective spindle assembly checkpoint, mutants fail to sustain MPF activity, allowing them to pass through mitosis and into the next cell cycle with lethal consequences [18, 19] . Components of the spindleassembly checkpoint are conserved between budding yeast, fission yeast, frogs and mammals [23] [24] [25] .
Here, we show that budding yeast cdc55 mutants define a novel class of spindle assembly checkpoint mutants. CDC55 encodes a protein homologous to the B regulatory subunit of a type 2A protein phosphatase (PP2A) [26, 27] . Comparing cdc55 cells with the mad mutants reveals a novel pathway for exit from mitosis. In mad1, mad2 and mad3 mutants, spindle disruption fails to protect B-type cyclins from degradation. In contrast, cdc55 cells do not degrade B-type cyclins, although they still inactivate MPF and separate their sister chromatids. Replacement of inhibitory phosphorylation sites in Cdc28 with nonphosphorylatable residues allows cdc55 cells that lack spindles to sustain their MPF levels and prevent sister chromatid separation. We discuss these results with regard to the role of PP2A in cell-cycle regulation, mechanisms of escaping from mitotic arrest, and the roles of proteolysis and phosphorylation in sister chromatid cohesion.
Results

cdc55 mutants lack a functional spindle assembly checkpoint
Because the original screens for mitotic checkpoint mutants in budding yeast were not saturating [18, 19] , we performed another screen for mutants that were hypersensitive to the microtubule-depolymerizing drugs benomyl and nocodazole. We used similar criteria to those already described [19] to isolate putative spindle-assembly checkpoint mutants: hypersensitivity to benomyl and nocodazole, and re-budding accompanied by rapid loss of cell viability when exposed to concentrations of these drugs that arrest wild-type cells in mitosis.
One recessive mutant that passed all of these tests, designated JM215, was cloned by complementation using a genomic DNA library. Figure 1 shows a map of the rescuing clone. Sequencing the ends of the clone allowed us to identify the genomic DNA fragment as one containing two open reading frames: the CDC55 gene, which encodes a yeast homologue of the B subunit of a PP2A [26] ; and a sequence encoding an unidentified 147 amino-acid polypeptide. We constructed a deletion plasmid that removed the promoter and amino-terminal 280 codons of CDC55 but not the second open reading frame, replacing them with the HIS3 marker (Fig. 1) . Integration of this plasmid at the genomic locus resulted in a strain (cdc55⌬) with the same spindle-assembly checkpoint defects as JM215: increased sensitivity to benomyl on plates (Fig.  2a) , and rapid death in liquid media containing 10 g ml -1 nocodazole (Fig. 2b) . As with other mad mutants, this
Figure 1
Restriction map of the 2.8 kb SacI-Mlu1 Saccharomyces cerevisiae genomic DNA fragment that rescued the benomyl sensitivity and sporulation defect of JM215. The ends (300 bp) of the fragment were sequenced and compared with sequences in the Genbank database. This identified the DNA as a 2830 bp segment containing CDC55 and an unidentified open reading frame. A CDC55 deletion construct was made by inserting the HIS3 gene between the SpeI and BamHI sites as indicated.
SacI
(1) Of the six previously reported spindle-assembly checkpoint genes, BUB1, BUB2 and MAD2 have been shown to be required to sustain MPF activity when spindle microtubules are depolymerized [18, 19] . MPF is normally inactivated at the end of mitosis by cyclin B proteolysis, and preventing this destruction prevents exit from mitosis [4, 28] . We therefore wondered if the failure of mad mutants to arrest in mitosis resulted from their inability to prevent cyclin proteolysis. We looked at the levels of the yeast mitotic cyclins, Clb2 and Clb3 [29, 30] , in cells synchronously released from an ␣ factor (G1-phase) block into medium containing 10 g ml -1 nocodazole, a concentration that activates the spindle-assembly checkpoint in wild-type cells. Figure 3a shows that, in wild-type cells, nocodazole treatment stabilizes Clb2 and Clb3, leading to high levels of histone H1 kinase activity in Clb-associated Cdc28 (Fig.  3b) . In contrast, mad2 cells failed to prevent degradation of Clb2 and Clb3, and as a result the Clb-associated histone H1 kinase levels fell. We saw a similar fall of Clb protein levels and kinase activities in other spindle-assembly checkpoint mutants (mad1, mad3 and bub1; data not shown).
The behavior of the mitotic cyclins in cdc55⌬ cells differed from both wild-type and other spindle-assembly checkpoint mutants. Clb2 appeared stable in cdc55⌬ cells released from a G1 arrest into nocodazole (Fig. 3a) , but although histone H1 kinase activity initially rose (a little slower than in wild-type cells, probably resulting from its longer doubling time), the mutant was unable to sustain high kinase levels (Fig. 3b) . Histone H1 kinase activity of Clb2 immunoprecipitates containing equivalent amounts of Cdc28 (as judged by western blotting with anti-PSTAIRE antibodies) was 3-5-fold lower in nocodazoletreated cdc55⌬ cells than in wild-type cells.
Loss of MPF activity correlates with sister chromatid separation
If sister chromatids separate before they have attached to the spindle, they will presumably segregate randomly with respect to each other. Thus, to prevent the generation of Research Paper PP2A regulates MPF and sister chromatid cohesion Minshull et al. 1611
Figure 2
Benomyl sensitivity of JM215, mad2⌬ and cdc55⌬. (a) Yeast were grown in YPD overnight, diluted to A 600 1.0 and four serial 10-fold dilutions were replicated onto YPD plates containing no additions (left) or 7.5 g ml -1 benomyl (right). The plates were incubated at 23°C for 2 days. (b) Yeast were grown overnight in YPD to mid-log phase, then diluted to A 600 0.3 in YPD containing 10 g ml -1 nocodazole ± 10 mg ml -1 hydroxyurea. Samples were withdrawn at 90 min intervals, diluted 5000-fold, and 200 l was spread onto a YPD plate which was incubated at 23°C for 3 days. The number of colonies was compared with the number immediately before nocodazole addition to determine the percent remaining viable. aneuploidy, the spindle assembly checkpoint should prevent sister separation as well as the inactivation of MPF. We therefore investigated whether sister separation occurred in mutants that inactivated the spindle assembly checkpoint.
We used two assays to monitor sister chromatid linkage. The first was a modification of existing in situ hybridization protocols [31, 32] that allowed the ribosomal DNA (rDNA) locus on chromosome XII to be localized in cells that had not been subjected to proteolysis [33] . The second was a novel technique based on the binding of a fusion protein, GFP-LacI (green fluorescent protein fused to the Lac repressor), to a 10 kb array consisting of 256 tandem repeats of the Lac operator (LacO) integrated into chromosome III [34] . Figure 4 shows chromosomes in nocodazole-treated wildtype and cdc55⌬ cells visualized either by in situ hybridization or by induction of the GFP-LacI fusion. In both cases, a single signal was seen in wild-type cells and two separate signals were seen in cdc55⌬ cells, indicating that an intact spindle-assembly checkpoint is required to maintain sister chromatid linkage in cells whose spindles have been depolymerized. The two sister separation assays gave quantitatively very similar results (data not shown).
We used the LacO-tagged chromosome to compare the effects of the two different classes of spindle-assembly checkpoint mutant on sister chromatid separation in cells whose spindle had been depolymerized by nocodazole treatment. Figure 5 shows that less than 5 % of wild-type cells arrested in nocodazole had two fluorescent spots in their nuclei, indicating that sister chromatids had not separated by more than the resolution limit of the light microscope (0.2 m). In both mad2⌬ and cdc55⌬ cells, however, a dramatic increase in the fraction of nuclei containing two spots coincided with the drop in MPF activity, showing that defects in the spindle-assembly checkpoint allow both MPF inactivation and sister separation in cells that 60  90  120  150  180  210  240  270  0  60  90  120  150  180  210  240  270  0  60  90  120  150  180  210  240  270  0  60  90  120  150  180  210  240  270 Clb2 protein and associated kinase levels in wild-type, mad2⌬, cdc55⌬ and cdc55⌬, Cdc28-VF cells. (a) The four yeast strains were grown overnight in YPD to mid-log phase, then diluted to A 600 0.3 in YPD containing 10 g ml -1 ␣ factor. Cells were arrested for 150 min, then washed into YPD containing 10 g ml -1 nocodazole. ␣ factor was added back to the cultures 90 min after the nocodazole to prevent reaccumulation of Clb2 in cells that had exited from mitosis. Samples were taken at 30 min intervals, lysed and immunoblotted for Clb2 and Clb3 proteins. This experiment was repeated five times with similar results. (b) Clb2 was immunoprecipitated from samples of the lysates prepared in (a). The immunoprecipitates were tested for their ability to phosphorylate histone H1. The kinase reactions were run on a 15 % polyacrylamide gel and radiolabeled phosphate incorporation was measured using a Molecular Dynamics Phosphorimager.
lack spindles. In the mad2⌬ mutant, sister separation also coincided with Clb2 proteolysis, but there was no such proteolysis seen in cdc55⌬ cells (compare Fig. 3a ,b with Fig. 5 ).
To confirm that the GFP-LacI signal was indeed measuring sister chromatid separation, we also used in situ hybridization to assess the degree of sister chromatid association (data not shown). The two methods gave quantitatively similar results and both showed that the fraction of nuclei containing separated sister chromatids in nocodazole-treated mad2⌬ or cdc55⌬ cells never exceeded 50-60 %. Nuclei with a single spot could reflect either the lack of sister chromatid separation in a fraction of the nuclei, or the presence of nuclei in which the marked sisters had separated but could not be resolved by light microscopy.
Cdc28-VF prevents MPF inactivation and sister chromatid separation
How is MPF inactivated in the absence of cyclin proteolysis in cdc55⌬ cells? We failed to detect dissociation of Cdc28 from Clb2, or the presence of non-covalently bound Cdc28 inhibitors in cdc55⌬ cells (data not shown). In fission yeast and vertebrate cells, the kinase activity of p34 cdc2 (the Cdc28 homolog) is inhibited during G2 by phosphorylation of threonine and tyrosine (Thr14 and Tyr15) residues [35] [36] [37] [38] in the ATP-binding site of the enzyme [39] . The homologous residues in Cdc28 are Thr18 and Tyr19, and phosphorylation of Tyr19 has been shown to inhibit Cdc28 H1 kinase activity in Saccharomyces cerevisiae [40] . To test whether cdc55⌬ cells inactivate MPF by inducing inhibitory phosphorylations on Cdc28, we made a cdc55⌬ strain containing a mutant cdc28 gene in which Thr18 was changed to Val18 and Tyr19 to Phe19 (cdc28-VF) [40] . Figure 3b shows that the H1 kinase activity of Clb2 immunoprecipitates prepared from nocodazoletreated cultures of the cdc55⌬ cdc28-VF double mutant strain was sustained rather than falling as it did in cdc55⌬. Thus, cdc55⌬ mutants are able to prevent Clb degradation in response to nocodazole, but inactivate Cdc28-associated H1 kinase activity of MPF through a pathway that requires the presence of phosphorylatable residues at Thr18 and Tyr19. By contrast, in mad1 and mad2 mutants, replacement of the normal CDC28 gene by cdc28-VF failed to prevent the loss of Clb-associated H1 kinase activity in nocodazole-treated cells (data not shown), demonstrating that the primary defect in these mutants is the inability of spindle defects to prevent activation of the cyclin proteolysis machinery. Although the cdc55⌬ cdc28-VF double mutant arrests in mitosis when treated with nocodazole, the cells still die. We do not know whether this lethality is due to the role of Cdc55 in the spindle-assembly checkpoint or to its involvement in other processes such as cellwall formation and morphogenesis [26] .
Examination of sister chromatid separation in nocodazoletreated cdc55⌬ cdc28-VF cells revealed that, in addition to preventing a loss of MPF activity, the non-phosphorylatable residues in Cdc28 also prevented sister chromatid separation (Fig. 5) . cdc55⌬ cells in which Cdc28 was 
Cdc28 is tyrosine-phosphorylated in cdc55⌬ cells treated with nocodazole
The results described above suggest that cdc55⌬ cells treated with nocodazole escape from mitosis by phosphorylating Cdc28 on sites that inhibit its protein kinase activity. To test this idea directly, we used western blotting with anti-phosphotyrosine antibodies to assay the tyrosine phosphorylation of Cdc28 in exponentially growing and nocodazole-treated cells. Figure 6 shows that asynchronous or nocodazole-treated wild-type cells had very little phosphotyrosine in Cdc28. By contrast, Cdc28 from nocodazole-treated or asynchronous cdc55⌬ cells contained easily detectable phosphotyrosine. As expected, nocodazole-treated cdc55⌬ cells whose wildtype CDC28 gene had been replaced by the cdc28-VF gene had no detectable phosphotyrosine on Cdc28. We conclude that the mechanism of MPF inactivation in nocodazole-treated cdc55⌬ cells is inhibitory phosphorylation of Cdc28. The observation that no phosphotyrosine is seen on Cdc28 in ␣ factor-treated cells is consistent with the inability of Wee1 to phosphorylate Cdc2 that is not complexed with cyclin B [41] .
Cytoplasmic PP2A activity is unaltered in mitotically arrested cells lacking Cdc55
As Cdc55 is homologous to the mammalian B-regulatory subunit of PP2A [26] , we wished to know whether PP2A activity differed between wild-type and cdc55⌬ cells. Using MPF-phosphorylated histone H1 as a substrate [42] , we measured the PP2A activity of yeast cell lysates as the protein phosphatase activity that was insensitive to inhibitors of protein phosphatase I but was sensitive to okadaic acid, a potent inhibitor of PP2A [27, 42, 43] . As shown in Figure 7 , we could detect only a small difference between PP2A activity in nocodazole-treated wild-type and cdc55⌬ cells. We wondered if the lack of difference could be because wild-type cells were arrested in mitosis, whereas the cdc55⌬ mutants were not, but we saw no change in PP2A activity in cdc55⌬ cells 150-240 minutes after addition of nocodazole, during which time H1 kinase activity was reduced 4-fold ( Fig. 3b and data not shown) . We conclude that the bulk cytoplasmic levels of PP2A are indistinguishable in wild-type and cdc55⌬ cells, consistent with previous observations using lysates from asynchronous wild-type and cdc55⌬ cultures [27] . Sister chromatid separation in spindleassembly checkpoint mutants. Four yeast strains were grown overnight in YPD to midlog phase, then diluted to A 600 0.3 in YPD containing 10 g ml -1 ␣ factor. Cells were arrested for 120 min, then washed into complete minimal media lacking histidine and containing 10 g ml -1 ␣ factor and 10 mM aminotriazole to induce expression of LacI-GFP. After a further 30 min, cells were washed into media containing 10 g ml -1 nocodazole. ␣ factor was added 90 min after the nocodazole to prevent reaccumulation of Clbs in cells that had exited from mitosis. Duplicate samples were taken at 30 min intervals. One set was lysed, Clb2 immunoprecipitated from the samples and immunoprecipitates tested for their ability to phosphorylate histone H1. The other set was washed, fixed and scored for the presence of one or two GFP-staining spots in the yeast nucleus. The data shown in this figure comes from the same experiment shown in Fig. 3 . The homologs of Thr18 and Tyr 19 (Thr14 and Tyr15) are located within the ATP-binding site of Cdk2 [39] , and phosphorylation of these sites been shown to inhibit kinase activity [40, 44] . Inhibitory phosphorylation in the ATP-binding site of p34 cdc2 (the Cdc28 homolog in other eukaryotes) has been implicated in the checkpoint that prevents premature MPF activation in both fission yeast and frogs ( [37, 38, 45] , but see also [46] ). Studies in budding yeast, however, have shown that mutation of amino acids Thr18 and Tyr19 does not affect the ability of DNA synthesis inhibitors to arrest the cell cycle [47, 48] . Phosphorylation of Cdc28 is involved in a checkpoint that inhibits passage through mitosis in cells that have not budded, and which may be analogous to the G2/M transition in other eukaryotes [49] . Here, we have shown that, as well as preventing entry into mitosis, phosphorylation of Thr18 and Tyr19 can cause a mitotic cell to progress to interphase when cyclin proteolysis has been prevented by the spindle-assembly checkpoint. Thus, the same set of modifications can both prevent entry into mitosis and induce exit from mitosis.
Sister chromatids separate when MPF activity falls
We have shown that budding yeast mutants with defects in the spindle-assembly checkpoint separate their sister chromatids despite their failure to assemble a spindle.
Cells lacking the MAD2 gene separate their sisters at
Research Paper PP2A regulates MPF and sister chromatid cohesion Minshull et al. 1615
Figure 6
Tyrosine phosphorylation of Cdc28 in cdc55⌬ mutants. Extracts of the indicated strains growing asynchronously or treated for 2.5 h with 10 g ml -1 of ␣ factor or 15 g ml -1 of nocodazole were analyzed for tyrosine phosphorylation of Cdc28. All strains carried hemagglutinin (HA)-tagged Cdc28, which was immunoprecipitated with an anti-HA antibody (12CA5). The immunoprecipitates were western blotted with an antiphosphotyrosine antibody, before stripping the blots and reprobing them with the anti-HA antibody (16B12) as a control for equal loading. 
Figure 7
Phosphatase 2A activity in wild-type and cdc55⌬ cells. Wild-type and cdc55⌬ cells were released from ␣ factor into nocodazole for 150 min.
Lysates were prepared and assayed for phosphatase activity (see Materials and methods). Both samples were incubated in the presence of inhibitor I2 to inhibit phosphatase 1 activity. The samples in the open bars contained no other inhibitor, whereas those in the dark grey bars also contained okadaic acid, an inhibitor of protein phosphatase 2A (PP2A). The light gray bars represent the difference between the activities measured in the presence and absence of okadaic acid. We attribute this difference to PP2A activity. Duplicate samples were taken at 0, 15 and 30 min, during which time inorganic phosphate release (measured as described in [42] ) was linear, and less than 10 % of the substrate was dephosphorylated. The bars indicate half of the range between the duplicate measurements. about the same time that they degrade the Clb2 B-type cyclins. The destruction of the mitotic cyclins is mediated by a cyclin-ubiquitinating complex that contains the Cdc16, Cdc23 and Cdc27 proteins [8] [9] [10] . Experimental modifications of cyclin structure or expression that prevent MPF inactivation do not prevent sister separation, as long as the cyclin-proteolysis machinery remains active [5, 50] . These observations have suggested that non-cyclin proteins must be degraded to allow sister separation, and recent experiments in fission yeast show that Cut2 destruction by the cyclin proteolysis machinery is required for sister separation [6] . We were therefore surprised to find that nocodazole-treated cdc55⌬ cells also separate their sisters as MPF levels fall, despite the lack of significant Clb proteolysis. Furthermore, a strain that was both cdc55⌬ and contained Cdc28-VF was not only able to sustain MPF activity when treated with nocodazole, but also maintained sister chromatid cohesion.
Although we observed no significant cyclin proteolysis in cdc55⌬ cells, we have not been able to show conclusively that exit from mitosis can occur in the absence of the cyclinproteolysis machinery. A simple test of this hypothesis would be to combine cdc55⌬ with a mutant, such as cdc16, cdc23 or cdc27, which inactivates the cyclin proteolysis machinery [9, 10, 51, 52] . Unfortunately, these latter mutations produce a large increase in the Clb concentrations at the non-permissive temperature (data not shown). As a result, in double mutants, the 3-5-fold decrease in Cdc28-associated kinase induced by removal of Cdc55 does not reduce MPF activity below that of wild-type mitotic cells.
Until a rigorous test of the role of the cyclin-proteolysis machinery can be performed, there are three hypotheses that can account for sister separation in nocodazole-treated cdc55⌬ cells. In the first model, proteolysis is required for separation, but cells regulate access of substrates to the cyclin-proteolysis machinery, thus allowing mitotic cyclins to remain stable, while proteins that prevent sister separation, such as Cut2 [6] are destroyed. In this model, however, it is unclear why the cdc28-VF mutant should prevent sister separation in nocodazole-treated cdc55⌬ cells. In the second model, the phosphorylation of chromosomal proteins by chromosome-associated MPF maintains sister cohesion until MPF inactivation induces anaphase. Manipulations that prevent the overall level of cyclin from falling allow sisters to separate because they do not prevent the local inactivation of MPF on the chromosome. In this model, however, it is unclear why the overproduction of wild-type Clb2 in budding yeast (the sole mitotic cyclin required for viability) should disrupt putative chromosome-associated MPF and lead to sister separation.
In the third model, either MPF inactivation or activation of the cyclin-proteolysis machinery can induce sister separation (Fig. 8) . Entry into mitosis would induce activities that could cause sister separation, but these activities would be kept in check by regulatory molecules until the onset of anaphase. If these inhibitors of separation were only active when they carried MPF-induced phosphorylations, and were substrates for the cyclin proteolysis machinery, either MPF activation or activation of the cyclin proteolysis machinery would induce anaphase (Fig. 8) . Thus, in unusual situations, like that of nocodazole-treated cdc55⌬ cells, inactivation of MPF without cyclin proteolysis would induce sister separation. Pds1 in budding yeast and Cut2 in fission yeast are candidates for proteins that act during metaphase to inhibit sister separation: deletion of Pds1 allows sister separation in cells arrested in mitosis by the spindle-assembly checkpoint or defects in the cyclin proteolysis machinery [7] , and preventing Cut2 destruction at the onset of anaphase prevents sister separation [6] .
The role of PP2A in mitosis
We believe that the failure of the spindle-assembly checkpoint resulting from deletion of the CDC55 gene is probably caused by inappropriate regulation of PP2A. Cdc55 is homologous to the PP2A regulatory subunit B from mammalian cells [26] , and Cdc55 is one component of the budding yeast PP2A-like phosphatase that is activated in response to ceramide [27] . We found little difference between PP2A activities in cytoplasmic extracts made from wild-type and cdc55⌬ cells, as measured by activity against MPF-phosphorylated histone H1. Our results are comparable with previous studies in which no difference was found in the abilities of asynchronous wild-type and cdc55⌬ yeast extracts to dephosphorylate phosphohistone H1 [27] .
Interpreting the results of these experiments is made difficult by the complex regulation of PP2A. Regulatory subunits of PP2A can either stimulate or inhibit the phosphatase activity of catalytic subunits, depending on the substrate [42, [53] [54] [55] . Experiments using purified vertebrate PP2A show that phosphatase activities against CDKphosphorylated histone H1, caldesmon and HMG-I(Y) are greatly decreased in the absence of regulatory subunits [42] . We have, so far, only been able to measure the phosphatase activities of crude yeast lysates rather than purified phosphatases. In addition, a number of PP2A catalytic subunits have been identified in budding yeast (Pph21, Pph22, Pph3 and the considerably more distantly related Sit4). To allow us to assay the activity of the purified phosphatase from yeast, we are currently trying to determine which proteins interact with Cdc55 in its role in maintaining the spindle-assembly checkpoint. Possibilities include the PP2A catalytic subunits as well as Tpd3 (a homolog of the regulatory A subunit of PP2A). Tpd3 and Sit4 have been implicated with Cdc55 as components of a ceramideinduced PP2A activity [27] .
A Cdc55-regulated phosphatase could regulate the spindleassembly checkpoint by controlling the kinases and phosphatases that modulate Cdc28 activity. The inhibitory tyrosine residue on Cdc28 is phosphorylated by Swe1 and dephosphorylated by Mih1 (homologs of the fission yeast Wee1 and Cdc25 proteins, respectively). In vitro evidence suggests that the vertebrate homologs of these proteins may be regulated by PP2A [56, 57] . In fission yeast and frogs, PP2A has been shown to prevent MPF activation in interphase cells and to stimulate MPF inactivation in mitotic ones [58] [59] [60] [61] [62] [63] . We propose that Cdc55 acts directly or indirectly to maintain Mih1 activity and to inhibit Swe1 activity in cells with defective spindles, thereby keeping MPF activity high and arresting cells in mitosis. Lack of Cdc55 would alter this balance, leading to inhibition of Mih1, activation of Swe1, inhibitory phosphorylation of Cdc28, and inactivation of MPF.
It is also possible that PP2A has a role in reversing the mitotic phosphorylations effected by MPF or its downstream kinases, in addition to its role in regulating MPF activity. Three lines of evidence support this idea: in vitro, PP2A dephosphorylates physiological substrates of cyclindependent kinases [42] ; the potent PP2A inhibitor okadaic acid prevents sister chromatid separation in mammalian cells [64] ; and the lack of the Drosophila 55 kDa PP2A B subunit results in abnormal anaphases [65] . Whether or not the same is true in S. cerevisiae remains to be seen.
Finally, we would like to know what function Cdc55 has in exit from the spindle-assembly checkpoint. Exit from mitosis normally requires cyclin degradation, and nondegradable cyclins arrest cells in mitosis [4, 28] . In the checkpoint arrest, however, cdc55⌬ cells inactivate MPF and return to interphase despite the presence of high levels of B-type cyclins associated with Cdc28. This may reflect a difference between normal mitotic control and the control of aberrant mitoses. Exit from the mitotic checkpoint occurs once the chromosomes have successfully attached to the spindle (recovery) [12] [13] [14] 16] . It has also been observed that cells that are unable to assemble a spindle will eventually exit from mitosis, despite presumably never receiving the signal that the mitotic apparatus has been successfully assembled (adaptation) [66] [67] [68] . In either of these cases, it is possible that rather than reversing the stabilization of B-type cyclins effected by the spindle assembly checkpoint, cells simply bypass the proteolytic mechanisms and inactivate MPF by phosphorylating the inhibitory sites on Cdc28.
Conclusions
We conclude that absence of the Cdc55 protein perturbs PP2A activity in a way that allows MPF to be inactivated by inhibitory phosphorylation instead of by cyclin destruction. Preventing the inhibitory phosphorylation of Cdc28 blocks sister chromatid separation. Thus, in cdc55⌬ cells treated with nocodazole, sister chromatid separation appears to be regulated by MPF activity rather than protein degradation.
Materials and methods
Strains and media
All strains used in this paper were derived from strain AFS34, an isogenic derivative of W303a. Gene transplacements and deletions or disruptions were performed by the one-step gene disruption method [69] . MAD2 was deleted using a disruption construct that removed the entire open reading frame (R-H. Chen the SpeI site (nucleotide 817) and an end-filled BamHI site nucleotide 1756) as shown in Fig. 1 . The SacI-MluI fragment was then used to transform wild-type W303 and HIS + transformants were selected. Transformants were checked for integration of the HIS3 into the genomic CDC55 gene by the polymerase chain reaction. Mutants of CDC28 in which Thr18 was replaced by Val and Tyr19 by Phe were made as described previously [40] . GFP-LacI under the control of the HIS3 promoter was integrated at the HIS3 locus by integration of plasmid pAFS78 after NheI digestion [34] . Lac operator repeats [70] were integrated at the LEU2 locus by integration of plasmid pAFS59 after EcoRV digestion [34] . All cells used were MATa.
Yeast media, ␣ factor, benomyl and hydroxyurea were prepared and used as described previously [19, 21, 68] . Nocodazole was purchased from Sigma, dissolved to 10 mg ml -1 in dimethylsulfoxide and this stock was diluted 1000-fold into media. All yeast were grown at 23°C to ensure consistent effects of microtubule-depolymerizing drugs.
Cloning and sequencing
CDC55 was cloned using a yeast genomic DNA library in YCp50 [21] to rescue the benomyl sensitivity of JM215 on YPD plates. A 10 kb rescuing fragment was restriction mapped and subcloned, and subclones were tested for their ability to rescue the JM215 benomyl sensitive phenotype. The ends of a positive 2.8 kb SacI-MluI fragment in pRS303 were sequenced by the chain termination method [71] using Sequenase from USB, following the manufacturers' directions. The sequences were compared with sequences in Genbank and found to be identical with the ends of a 2830 bp SacI-MluI piece of the S. cerevisiae genome located on chromosome VIII, containing the gene for CDC55, and an unidentified open reading frame. Restriction mapping of our subclone with a number of enzymes gave the patterns predicted by the yeast genomic sequence.
Cell death in nocodazole
The rate of death of strains with depolymerized microtubules were measured by a modification of the method described in [19] , as described in the legend to Figure 2b .
Western blotting: Clb2 and anti-phosphotyrosine
Yeast lysates were prepared as previously described [72] . Proteins were separated by polyacrylamide gel electrophoresis [73] and immunoblotted for Clb2 and Clb3 using previously described antibodies [74] . Phosphotyrosine was detected by probing the blots with a rabbit polyclonal antibody from Zymed Laboratories.
Histone H1 kinase assay
Clb2 was immunoprecipitated from yeast lysates and used to phosphorylate histone H1 as described previously [72] .
Chromosome staining: in situ hybridization and GFP-LacI
Log-phase cultures of strains -AFS173 (wild-type), AFS176 (mad2), JM480 (cdc55⌬) and JM477 (cdc55⌬ cdc28-VF) -containing GFP-LacI under control of the HIS3 promoter and Lac operator repeats integrated at the LEU2 locus on chromosome 3, were induced for 30 min in CSM-HIS plus 10 mM 3-aminotriazole. After removal of 3-aminotriazole, cells were resuspended in YPD with or without 10g ml -1 nocodazole. Cultures were fixed for 30 min in 3.7 % formaldehyde and the GFP-LacI staining was visualized using conventional fluorescence microscopy. For further details, see [34] . The fraction of cells with separated sister chromatids was then calculated for each cell population.
In situ hybridization was performed to intact, fixed yeast cells after enzymatic removal of the cell wall. Cultures were grown to mid log phase, fixed with paraformaldehyde, spheroplasted with Zymolyase 100-T (Seikagaku), and the cells adhered to polylysine-coated coverslips. In these experiments, the probe was a cloned yeast rDNA repeat; the plasmid was fragmented and 3′-end labeled with Rhodamine-4-dUTP (FluoroRed, Amersham) using terminal deoxynucleotidyl transferase (TdT, Promega). Fixation and hybridization to S. cerevisiae cells are described in greater detail elsewhere [33] .
Phosphatase assay
Calf histone H1 (Boehringer Mannheim) was phosphorylated to 3.5 mol phosphate per mol H1 by Xenopus MPF as follows. MPF was bound to p13 suc1 beads and washed as described previously [75, 76] . The bead-bound MPF was incubated in 80 mM Na ␤-glycerophosphate (pH 7.4), 15 mM MgCl 2 , 20 mM EGTA, 1 mM ATP (0.8 mCi ml -1 ), 2 mM DTT, 60 M histone H1 for 6 h at 30°C. Histone H1 was separated from bead-bound MPF and free label by loading 100 l aliquots of the entire phosphorylation reaction onto 1 ml Sepharose G-50 spin columns equilibrated with 10 mM Tris-Cl (pH 7.4), 1 mM EDTA, 15 mM 2-mercaptoethanol. Yeast lysates were made as described previously [43] . Lysates were diluted to 0.1 mg ml -1 protein in 50 mM Tris-Cl (pH 7.5), 1 mM EDTA, 15 mM 2-mercaptoethanol, 0.3 mg ml -1 bovine serum albumin (Boehringer Mannheim), 100 nM inhibitor I2 and, in some cases, 2 nM okadaic acid [43, 77] . Phosphohistone H1 was added to 5 M and phosphatase activity was measured by the release of inorganic phosphate from histone H1 [42] .
